Melanoma Risk-Reduction Among Patients and Family Members

NCT00510302 | Completed

• 1 other identifier: ID02-452
• Study Type: observational
• Target: 170
• Locations: 1 country
• Sites: 1

Brief Summary

Primary Objectives:

• To conduct semi-structured interviews with melanoma patients and family members to collect descriptive information on their UVR exposure, UVR exposure-reduction practices, melanoma early detection practices, knowledge, psychosocial variables related to melanoma risk-reduction (e.g., self-efficacy, norms, and expectations), and experiences surrounding the diagnosis of melanoma in the family. Melanoma patients and family members with children will be asked about the UVR exposure and UVR exposure-reduction practices of their children, and parental practices to reduce UVR exposure among children.
• To develop behavioral and attitudinal questionnaires based on data collected during semi-structured interviews, and evaluate the appropriateness of these questionnaires using cognitive interviewing techniques.
• To develop tailored messages aimed at promoting strategies to reduce UVR exposure (e.g., wearing protective clothing, minimizing midday UVR exposure, minimizing duration of UVR exposure, using shade and sunscreen, avoiding sun lamps, and avoiding intentional tanning) and improving adherence to surveillance and screening guidelines. Messages will be developed to correspond to responses to questionnaire items.
• To assess tailored messages for their relevance, appropriateness, attractiveness and appeal, credibility, and perceived behavioral impact among melanoma patients and their family members.

Conditions

Melanoma

Keywords

Ultraviolet Radiation; Melanoma; Questionnaire; Survey; First Degree Relative; Interview

Outcome Measures

Primary Outcomes (1)

• Information on ultraviolet radiation (UVR-E) reduction + early detection practices of melanoma patients and family members

  8 Years

Secondary Outcomes (1)

• Development of questionnaires + tailored intervention messages on melanoma risk-reduction in a high-risk population

  8 years

Study Arms (1)

Melanoma Risk-Reduction

Patients with melanoma, their spouses/partners, and first-degree relatives (FDRs).

Behavioral: Questionnaire; Behavioral: Interview

Interventions

Questionnaire BEHAVIORAL

Questionnaire regarding melanoma risk-reduction.

Also known as: Survey

Melanoma Risk-Reduction

Interview BEHAVIORAL

Interview via telephone about topics related to melanoma risk-reduction.

Melanoma Risk-Reduction

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with melanoma, their spouses/partners, and first-degree relatives (FDRs).

You may qualify if:

• (FDRs will include siblings and adult children.) Melanoma patients are eligible if they were diagnosed with in situ, localized, or regional melanoma after January 1, 1997.
• Melanoma patients, their spouses/partners, and their first-degree relatives (FDRs) 18 years of age or older are eligible.
• Melanoma patients, their spouses/partners, and FDRs are eligible if they can speak, read, and write English.
• Melanoma patients, their spouses/partners, and FDRs are eligible if they provide informed consent.
• Spouses/partners and FDRs of melanoma patients are eligible if the patient gives permission for them to be contacted for recruitment.
• A melanoma patient's FDR is eligible if he/she is a sibling or child of the melanoma patient.

You may not qualify if:

• Melanoma patients, spouses/partners of patients, and FDRs of patients are not eligible if they cannot provide informed consent.

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• University of Texas MD Anderson Cancer Center Website

MeSH Terms

Conditions

Melanoma

Interventions

Surveys and Questionnaires; Interviews as Topic

Condition Hierarchy (Ancestors)

Neuroendocrine Tumors; Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms; Neoplasms, Nerve Tissue; Nevi and Melanomas; Skin Neoplasms; Neoplasms by Site; Skin Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Susan Peterson, PhD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: FAMILY BASED
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 31, 2007
• First Posted: August 2, 2007
• Study Start: November 18, 2002
• Primary Completion: September 14, 2020
• Study Completion: September 14, 2020
• Last Updated: September 16, 2020

Record last verified: 2020-09

Locations

US (1)